Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor
2011
Identifying p160 as a Target of the VHL Tumor Suppressor
publication
Evidence: moderate
Author Information
Author(s): Lai Yan, Qiao Mei, Song Meihua, Weintraub Susan T., Shiio Yuzuru
Primary Institution: Greehey Children's Cancer Research Institute, San Antonio, Texas, United States of America
Hypothesis
Can quantitative proteomics identify novel substrates of the VHL tumor suppressor?
Conclusion
The study identified the Myb-binding protein p160 as a novel substrate of the VHL tumor suppressor, which is degraded in an iron-dependent manner.
Supporting Evidence
- The study confirmed that p160 is upregulated when VHL is not functional.
- VHL was shown to directly bind and degrade p160.
- Degradation of p160 by VHL requires iron, similar to the regulation of HIF.
Takeaway
Researchers found that a protein called p160 is broken down by a tumor suppressor called VHL, which helps control cancer growth.
Methodology
The study used quantitative proteomics to identify VHL substrates by comparing protein expression in cells with and without functional VHL.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website